1 – 32 of 32
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance
(
- Contribution to journal › Article
-
Mark
Deciphering the genetics and mechanisms of predisposition to multiple myeloma
(
- Contribution to journal › Article
- 2022
-
Mark
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6
(
- Contribution to journal › Letter
-
Mark
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
(
- Contribution to journal › Article
- 2021
-
Mark
Characterization of rare germline variants in familial multiple myeloma
(
- Contribution to journal › Letter
-
Mark
Search for AL amyloidosis risk factors using Mendelian randomization
(
- Contribution to journal › Article
-
Mark
Germline variants at SOHLH2 influence multiple myeloma risk
(
- Contribution to journal › Article
- 2020
-
Mark
Search for multiple myeloma risk factors using Mendelian randomization
(
- Contribution to journal › Article
- 2019
-
Mark
Genome-wide interaction and pathway-based identification of key regulators in multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS) : comparison with multiple myeloma
2019) In Leukemia(
- Contribution to journal › Letter
-
Mark
Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance
(
- Contribution to journal › Letter
-
Mark
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes
(
- Contribution to journal › Article
- 2018
-
Mark
Bortezomib-induced peripheral neuropathy : A genome-wide association study on multiple myeloma patients
(
- Contribution to journal › Article
-
Mark
Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance : a genome-wide genetic interaction study
(
- Contribution to journal › Article
-
Mark
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
(
- Contribution to journal › Article
-
Mark
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
(
- Contribution to journal › Article
- 2017
-
Mark
Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy : Replication of the Reported Candidate Susceptibility Loci
(
- Contribution to journal › Article
-
Mark
Genomewide association study on monoclonal gammopathy of unknown significance (MGUS)
(
- Contribution to journal › Article
-
Mark
Direct evidence for a polygenic etiology in familial multiple myeloma
(
- Contribution to journal › Article
-
Mark
Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma
(
- Contribution to journal › Article
-
Mark
Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts
(
- Contribution to journal › Letter
-
Mark
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
(
- Contribution to journal › Article
- 2016
-
Mark
Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
(
- Contribution to journal › Article
- 2015
-
Mark
Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells.
(
- Contribution to journal › Article
-
Mark
The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells
(
- Contribution to journal › Letter
- 2014
-
Mark
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
(
- Contribution to journal › Article
- 2013
-
Mark
The CCND1 c.870G > A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
(
- Contribution to journal › Article
-
Mark
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
(
- Contribution to journal › Article
- 2012
-
Mark
Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
(
- Contribution to journal › Article